Evidence map›Paper›PMID 16925734›Full record

ArticleHIV medicine2006

Serum prostate-specific antigen levels in older men with or at risk of HIV infection.

L E Vianna, Y Lo, R S Klein

Open access · greenAbstract read
In one paragraph

Article in HIV medicine, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. HIV and prostate cancer: a systematic review of the literature.Prostate cancer and prostatic diseases · 2009
    Pooled it
  2. Trial
  3. Prostate cancer in people with HIV.Current opinion in infectious diseases · 2025
    Review
  4. Review
  5. Review
  6. Prostate-specific antigen: its relationship with alcohol intake and tobacco.Medical oncology (Northwood, London, England) · 2012
    Article
  7. Review
  8. Urologic complications of HIV and AIDS.Nature clinical practice. Urology · 2009
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

L E ViannaDivision of Infectious Diseases, Department of Medicine, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY 10467, USA.
Y Lo
R S Klein
Office of Infectious Diseases · USMontefiore Medical Center · US

Funding

Immunology/Pathology CoreP30AI051519 · NIAID · YESHIVA UNIVERSITY · PI GOLDSTEIN, HARRIS · 2003 to 2013
$18.6M
Artherosclerosis/bone loss/drug use/HIV in older menR01DA014998 · NIDA · MONTEFIORE MEDICAL CENTER (BRONX, NY) · PI KLEIN, ROBERT STEPHEN · 2002 to 2006
$5.3M
NIAID NIH HHS AI-051519NIAID NIH HHS P30 AI051519NIDA NIH HHS R01 DA014998NIDA NIH HHS R01 DA14998
6 · The paper itself

Abstract

objectivesThe aim of the study was to determine the rate of, and factors associated with, elevated prostate-specific antigen (PSA) levels in older men with or at risk of HIV infection.

methodsUsing a cross-sectional analysis, we interviewed 534 men > or =49 years old at risk for HIV infection on demographics, behaviours and medical history. Laboratory testing included serum PSA level and HIV serology, and T-cell subsets for those who were HIV seropositive. Elevated PSA level was defined as >4.0 ng/mL, and men with elevated PSA levels were referred for urological evaluation.

resultsFifteen per cent of men were white, 55% black, and 23% Hispanic; median age was 53 years (range 49-80 years); 74% were sexually active; 65% currently smoked cigarettes; and 16% had taken androgens. Among 310 HIV-positive men, CD4 counts were >500 cells/microL in 31%, 200-500 cells/microL in 51%, and <200 cells/microL in 19%. Twenty men (4%) had elevated PSA. On univariate analysis, only older age was significantly associated with elevated PSA, and there was no significant difference in the number of men with elevated PSA between HIV-positive and HIV-negative men (nine of 310 vs 11 of 224; P = 0.28). On multivariate analysis, older age remained the only variable associated with elevated PSA level [reference group < or =50 years; adjusted odds ratio (OR(adj)) 1.0 for age 51-60 years; OR(adj) 5.9 (95% confidence interval 1.2-30.1) for age > or =61 years] adjusted for HIV status, family history of prostate cancer, and androgen use.

conclusionsAmong older men, PSA levels increased with age but did not differ by HIV status. The clinical use of PSA levels in older men currently do not need to be modified for those with HIV infection.

Indexed as

AgedAged, 80 and overCD4 Lymphocyte CountCross-Sectional StudiesHIV InfectionsHumansMaleMiddle AgedProstate-Specific AntigenProstatic NeoplasmsRisk FactorsProstate-Specific Antigenageingmen's healthprostateprostate-specific antigen

Identifiers

PMID16925734
PMCPMC2435169
OpenAlexW2036550504

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.